Kumar S. Redefining operability after neoadjuvant therapy in pancreatic ductal adenocarcinoma: a biology-driven surgical framework. Int Surg J [Internet]. 2026 Oct. 27 [cited 2026 Oct. 28];13(11):2386-93. Available from: https://www.ijsurgery.com/index.php/isj/article/view/12475